Sanjay Chanda

Insider Reports History

Location
Woodside, CA
Signature
/s/ Lucy Day, Attorney-in-Fact for Sanjay Chanda
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sanjay Chanda:

Company Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Chief Development Officer Common Stock 118,823 $156,846 $1.32 20 Feb 2026 Direct
AN2 Therapeutics, Inc. Chief Development Officer Stock Option (right to buy) 77,000 20 Feb 2026 Direct

Insider Reports Filed by Sanjay Chanda

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ANTX AN2 Therapeutics, Inc. 20 Feb 2026 2 $0 4 Chief Development Officer 23 Feb 2026, 16:35
ANTX AN2 Therapeutics, Inc. 05 Jan 2026 2 -$9,332 4 Chief Development Officer 07 Jan 2026, 20:13
ANTX AN2 Therapeutics, Inc. 26 Feb 2025 2 $0 4 Chief Development Officer 28 Feb 2025, 16:27
ANTX AN2 Therapeutics, Inc. 03 Jan 2025 1 -$3,965 4 Chief Development Officer 07 Jan 2025, 20:00
ANTX AN2 Therapeutics, Inc. 15 Mar 2024 1 $0 4/A Chief Development Officer 29 Mar 2024, 16:16
ANTX AN2 Therapeutics, Inc. 15 Mar 2024 2 $0 4 Chief Development Officer 18 Mar 2024, 19:27
ANTX AN2 Therapeutics, Inc. 15 Feb 2023 1 $0 4 Chief Development Officer 17 Feb 2023, 18:28
ANTX AN2 Therapeutics, Inc. 12 May 2022 1 $0 4 Chief Development Officer 16 May 2022, 21:32
ANTX AN2 Therapeutics, Inc. 24 Mar 2022 0 $0 3 Chief Development Officer 24 Mar 2022, 21:19